Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.77M | -2.75M | -12.02M | 10.22M | -5.15M |
| Total Depreciation and Amortization | -379.00K | 153.00K | 289.00K | 21.00K | -287.00K |
| Total Amortization of Deferred Charges | 97.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.98M | -1.51M | 7.70M | -14.38M | 973.00K |
| Change in Net Operating Assets | 809.00K | -2.34M | 1.71M | 1.19M | 901.00K |
| Cash from Operations | -3.69M | -6.44M | -2.33M | -2.95M | -3.57M |
| Capital Expenditure | 0.00 | 0.00 | -12.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -12.00K | -- | 0.00 |
| Total Debt Issued | 0.00 | 200.00K | 1.66M | -- | -- |
| Total Debt Repaid | -111.00K | -461.00K | 0.00 | -233.00K | -234.00K |
| Issuance of Common Stock | 4.61M | 8.30M | 0.00 | 1.37M | 755.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.03M | -847.00K | -- | -- | -- |
| Total Dividends Paid | -310.00K | -347.00K | -- | -- | -- |
| Other Financing Activities | 0.00 | 100.00K | -68.00K | -100.00K | -- |
| Cash from Financing | 3.16M | 6.94M | 1.59M | 1.03M | 521.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -521.00K | 497.00K | -744.00K | -1.91M | -3.05M |